Agree. If they set out a clear pathway that isn't too onerous on 002-3 its a very big tick for PAR.
Duration in effective pain relief will also be massive to BP so it may not take much more convincing post the release of 365 day data points (plus MRI) to strike a discrete regional deal acceptable to both parties.
IMO the market sentiment seems overly focused on the short term. The next release may confirm just how badly the market has judged PAR's long term prospects.
Chart, page-3975
-
- There are more pages in this discussion • 308 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $265.4K | 1.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 130186 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 11571 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |